We recently reported that insulin-dependent inhibition of GSK3β, a kinase with a growing list of neurologic disease links (Dell'Osso et al., 2016), phosphorylates dynein and regulates its interactions with Ndel1 and APC (Gao et al., 2015; Gao et al., 2017). This evidence concerns the gene INS and nervous system disorder.